Sell Alert! Take a 130% Profit From Our December Trade… and Biotech Updates

By Ray BlancoPosted June 12, 2015

We're now up near 130% from our original entry price. That means we can reduce risk in our position in this biotech company by selling half our shares and recouping our original investment and then some. We can let the rest ride in what I expect will become a very successful biotech company.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Technology Profits Confidential

With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

Biotech Progress Reports From NewLink Genetics and Isis Pharmaceuticals

By Ray BlancoPosted April 5, 2013

I hope you’ve enjoyed the holiday. Coming back to nonholiday reality, the “consensus” is that things are going poorly in the world, indeed. Internationally, North Korea is throwing one of its periodic temper tantrums and issuing its usual threats, heightening tensions in an economically and politically important part of the world. Domestically, things aren’t sounding...

Life Extension Will Extend Investor Gains

By Ray BlancoPosted March 30, 2012

I'm packing my bags to head to San Francisco today. By the time you read this, I'll be traveling to this year's meeting of the Personalized Life Extension Conference. I'll be staying near San Francisco Intl., and just down the street from the conference location. San Francisco has some beautiful sights to see... but I think I left my heart in Rancho Santana, Nicaragua, during the Agora editorial meeting last week.

Vertex a Buy, Nvidia Taking Supercomputing to New Heights, TriQuint in New iPhone

By Ray BlancoPosted October 13, 2011

Vertex Pharmaceuticals has sold off the past few weeks based on fears of lower than hoped-for sales of its leading hepatitis C compound, as well as new competition nibbling at its heels. I think the company is now oversold for several reasons.

This Biotech Drops Almost 20% but It’s Still Worth Keeping… Here’s Why

By Ray BlancoPosted May 15, 2015

With biotech investing, it often makes sense to take some profits when a risky event is imminent.

Will Fantasy Beat Reality?

By Greg GuenthnerPosted October 14, 2016

Gerald Celente dives into how virtual & augmented realities are affecting this multi-billion dollar industry.

Chips Take the Lead in 2021

By Ray BlancoPosted January 13, 2021

Looking back at 2020, no one could have predicted the fallout that would have come with the COVID-19 outbreak at the beginning of the year. Even with all the turmoil, markets rocketed higher, with Big Tech carrying most of the weight up. So what’s in store for tech in 2021?

Login